$DXCM DEXCOM INC Insider Trading Week 10/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in DEXCOM INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in DEXCOM INC in week 10/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14 2014 | DXCM | DEXCOM INC | LISTER JOHN | General Counsel, VP ... | Option Exercise | M | 4.58 | 1,750 | 8,015 | 23,241 | |
| Mar 14 2014 | DXCM | DEXCOM INC | LISTER JOHN | General Counsel, VP ... | Sell | S | 45.01 | 1,409 | 63,419 | 120,542 | 122 K to 120.5 K (-1.16 %) |
| Mar 14 2014 | DXCM | DEXCOM INC | LISTER JOHN | General Counsel, VP ... | Sell | S | 45.38 | 5,999 | 272,246 | 121,951 | 128 K to 122 K (-4.69 %) |
| Mar 14 2014 | DXCM | DEXCOM INC | LISTER JOHN | General Counsel, VP ... | Sell | S | 45.01 | 1,750 | 78,768 | 127,950 | 129.7 K to 128 K (-1.35 %) |
| Mar 14 2014 | DXCM | DEXCOM INC | LISTER JOHN | General Counsel, VP ... | Buy | M | 4.58 | 1,750 | 8,015 | 129,700 | 128 K to 129.7 K (+1.37 %) |
| Mar 14 2014 | DXCM | DEXCOM INC | LISTER JOHN | General Counsel, VP ... | Sell | D | 45.22 | 4,562 | 206,301 | 127,950 | 132.5 K to 128 K (-3.44 %) |
| Mar 14 2014 | DXCM | DEXCOM INC | ROPER JESS | VP, CFO | Sell | D | 45.22 | 5,285 | 238,996 | 87,786 | 93.1 K to 87.8 K (-5.68 %) |
| Mar 14 2014 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | D | 45.22 | 12,616 | 570,516 | 241,399 | 254 K to 241.4 K (-4.97 %) |
| Mar 14 2014 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | D | 45.22 | 8,808 | 398,312 | 218,017 | 226.8 K to 218 K (-3.88 %) |
| Mar 14 2014 | DXCM | DEXCOM INC | SAYER KEVIN R | President & COO | Sell | D | 45.22 | 26,421 | 1,194,800 | 453,827 | 480.2 K to 453.8 K (-5.50 %) |
| Mar 13 2014 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | Sr. VP. Worldwide S ... | Option Exercise | M | 6.03 | 50,000 | 301,500 | 12,249 | |
| Mar 13 2014 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | Sr. VP. Worldwide S ... | Sell | D | 45.22 | 5,923 | 267,848 | 146,520 | 152.4 K to 146.5 K (-3.89 %) |
| Mar 13 2014 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | Sr. VP. Worldwide S ... | Sell | S | 46.42 | 50,000 | 2,321,245 | 152,443 | 202.4 K to 152.4 K (-24.70 %) |
| Mar 13 2014 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | Sr. VP. Worldwide S ... | Buy | M | 6.03 | 50,000 | 301,500 | 202,443 | 152.4 K to 202.4 K (+32.80 %) |
| Mar 13 2014 | DXCM | DEXCOM INC | GREGG TERRANCE H | CEO | Option Exercise | M | 8.95 | 20,000 | 179,000 | 340,000 | |
| Mar 13 2014 | DXCM | DEXCOM INC | GREGG TERRANCE H | CEO | Option Exercise | M | 8.95 | 10,000 | 89,500 | 360,000 | |
| Mar 13 2014 | DXCM | DEXCOM INC | GREGG TERRANCE H | CEO | Sell | S | 45.38 | 20,000 | 907,586 | 395,626 | 415.6 K to 395.6 K (-4.81 %) |
| Mar 13 2014 | DXCM | DEXCOM INC | GREGG TERRANCE H | CEO | Buy | M | 8.95 | 20,000 | 179,000 | 415,626 | 395.6 K to 415.6 K (+5.06 %) |
| Mar 13 2014 | DXCM | DEXCOM INC | GREGG TERRANCE H | CEO | Sell | S | 45.75 | 10,000 | 457,500 | 395,626 | 405.6 K to 395.6 K (-2.47 %) |
| Mar 13 2014 | DXCM | DEXCOM INC | GREGG TERRANCE H | CEO | Buy | M | 8.95 | 10,000 | 89,500 | 405,626 | 395.6 K to 405.6 K (+2.53 %) |
| Mar 13 2014 | DXCM | DEXCOM INC | Balo Andrew K | SVP, Regulatory and ... | Option Exercise | M | 7.25 | 5,054 | 36,642 | 50,000 | |
| Mar 13 2014 | DXCM | DEXCOM INC | Balo Andrew K | SVP, Regulatory and ... | Option Exercise | M | 7.25 | 4,946 | 35,859 | 0 | |
| Mar 13 2014 | DXCM | DEXCOM INC | Balo Andrew K | SVP, Regulatory and ... | Sell | D | 45.22 | 8,808 | 398,312 | 159,099 | 167.9 K to 159.1 K (-5.25 %) |
| Mar 13 2014 | DXCM | DEXCOM INC | Balo Andrew K | SVP, Regulatory and ... | Sell | S | 45.93 | 4,946 | 227,153 | 167,907 | 172.9 K to 167.9 K (-2.86 %) |
| Mar 13 2014 | DXCM | DEXCOM INC | Balo Andrew K | SVP, Regulatory and ... | Buy | M | 7.25 | 4,946 | 35,859 | 172,853 | 167.9 K to 172.9 K (+2.95 %) |
| Mar 13 2014 | DXCM | DEXCOM INC | Balo Andrew K | SVP, Regulatory and ... | Sell | S | 45.93 | 5,054 | 232,114 | 167,907 | 173 K to 167.9 K (-2.92 %) |
| Mar 13 2014 | DXCM | DEXCOM INC | Balo Andrew K | SVP, Regulatory and ... | Buy | M | 7.25 | 5,054 | 36,642 | 172,961 | 167.9 K to 173 K (+3.01 %) |
| Mar 13 2014 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 13.45 | 23,437 | 315,228 | 45,264 | |
| Mar 13 2014 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | D | 45.22 | 12,616 | 570,516 | 190,387 | 203 K to 190.4 K (-6.21 %) |
| Mar 13 2014 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 46.18 | 23,437 | 1,082,328 | 203,003 | 226.4 K to 203 K (-10.35 %) |
| Mar 13 2014 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 13.45 | 23,437 | 315,228 | 226,440 | 203 K to 226.4 K (+11.55 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Option Exercise | M | 0.00 | 16,000 | 0 | 97,000 | |
| Mar 11 2014 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | D | 46.10 | 12,850 | 592,403 | 203,003 | 215.9 K to 203 K (-5.95 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Sell | S | 46.57 | 16,000 | 745,120 | 215,853 | 231.9 K to 215.9 K (-6.90 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Buy | M | 3.19 | 16,000 | 51,040 | 231,853 | 215.9 K to 231.9 K (+7.41 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | VALDES JORGE A | CTO | Grant | A | 0.00 | 71,000 | 71 | 215,853 | 144.9 K to 215.9 K (+49.02 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Sell | D | 46.10 | 12,850 | 592,403 | 254,015 | 266.9 K to 254 K (-4.82 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | Pacelli Steven Robert | EVP, Strategy & Cor ... | Grant | A | 0.00 | 71,000 | 71 | 266,865 | 195.9 K to 266.9 K (+36.25 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | SAYER KEVIN R | President & COO | Sell | D | 46.10 | 8,414 | 387,898 | 480,248 | 488.7 K to 480.2 K (-1.72 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | SAYER KEVIN R | President & COO | Grant | A | 0.00 | 150,000 | 150 | 488,662 | 338.7 K to 488.7 K (+44.29 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Sell | D | 46.10 | 10,660 | 491,441 | 226,825 | 237.5 K to 226.8 K (-4.49 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | MOY JEFFREY | SVP, Operations | Grant | A | 0.00 | 50,000 | 50 | 237,485 | 187.5 K to 237.5 K (+26.67 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | Sr. VP. Worldwide S ... | Sell | D | 46.10 | 2,694 | 124,197 | 152,443 | 155.1 K to 152.4 K (-1.74 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | DOUBLEDAY RICHARD | Sr. VP. Worldwide S ... | Grant | A | 0.00 | 50,000 | 50 | 155,137 | 105.1 K to 155.1 K (+47.56 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | ROPER JESS | VP, CFO | Sell | D | 46.10 | 3,437 | 158,451 | 93,071 | 96.5 K to 93.1 K (-3.56 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | ROPER JESS | VP, CFO | Grant | A | 0.00 | 30,000 | 30 | 96,508 | 66.5 K to 96.5 K (+45.11 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | LISTER JOHN | General Counsel, VP ... | Sell | D | 46.10 | 3,814 | 175,831 | 132,512 | 136.3 K to 132.5 K (-2.80 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | LISTER JOHN | General Counsel, VP ... | Grant | A | 0.00 | 65,000 | 65 | 136,326 | 71.3 K to 136.3 K (+91.13 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | Balo Andrew K | SVP, Regulatory and ... | Sell | D | 46.10 | 6,578 | 303,255 | 167,907 | 174.5 K to 167.9 K (-3.77 %) |
| Mar 11 2014 | DXCM | DEXCOM INC | Balo Andrew K | SVP, Regulatory and ... | Grant | A | 0.00 | 50,000 | 50 | 174,485 | 124.5 K to 174.5 K (+40.17 %) |
| Mar 10 2014 | DXCM | DEXCOM INC | GREGG TERRANCE H | CEO | Option Exercise | M | 8.95 | 8,000 | 71,600 | 370,000 | |
| Mar 10 2014 | DXCM | DEXCOM INC | GREGG TERRANCE H | CEO | Option Exercise | M | 6.85 | 12,500 | 85,625 | 736,108 | |
| Mar 10 2014 | DXCM | DEXCOM INC | GREGG TERRANCE H | CEO | Grant | A | 0.00 | 182,813 | 183 | 395,626 | 212.8 K to 395.6 K (+85.90 %) |
| Mar 10 2014 | DXCM | DEXCOM INC | GREGG TERRANCE H | CEO | Sell | S | 48.02 | 12,500 | 600,230 | 212,813 | 225.3 K to 212.8 K (-5.55 %) |
| Mar 10 2014 | DXCM | DEXCOM INC | GREGG TERRANCE H | CEO | Buy | M | 6.85 | 12,500 | 85,625 | 225,313 | 212.8 K to 225.3 K (+5.87 %) |
| Mar 10 2014 | DXCM | DEXCOM INC | GREGG TERRANCE H | CEO | Sell | S | 47.51 | 8,000 | 380,090 | 212,813 | 220.8 K to 212.8 K (-3.62 %) |
| Mar 10 2014 | DXCM | DEXCOM INC | GREGG TERRANCE H | CEO | Buy | M | 8.95 | 8,000 | 71,600 | 220,813 | 212.8 K to 220.8 K (+3.76 %) |